We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+11.56%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$8.44B
AUM Growth
+$1.09B
(+15%)
Cap. Flow
+$577M
Cap. Flow
% of AUM
6.84%
Top 10 Holdings %
Top 10 Hldgs %
15.63%
Holding
838
New
218
Increased
181
Reduced
162
Closed
220
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$123M |
| 2 |
HES
Hess
HES
|
+$115M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$108M |
| 4 |
Cencora
COR
|
+$106M |
| 5 |
Microsoft
MSFT
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$108M |
| 2 |
Analog Devices
ADI
|
+$105M |
| 3 |
Keysight
KEYS
|
+$101M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$82.2M |
| 5 |
Booking.com
BKNG
|
+$58.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.55% |
| 2 | Technology | 28% |
| 3 | Industrials | 9.43% |
| 4 | Energy | 7.74% |
| 5 | Consumer Discretionary | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Acadia Pharmaceuticals
ACAD
$4.43B
| $19.9M | 0.24% |
830,355
+399,450
| +93% | +$8.88M |
|
127
ATI
ATI
$25.6B
| $19.7M | 0.23% |
+444,674
| New | +$17M |
|
128
Seagate
STX
$194B
| $19.5M | 0.23% |
+315,360
| New | +$19.3M |
|
129
Paycom
PAYC
$7.64B
| $19.5M | 0.23% |
60,727
-14,688
| -19% | -$4.33M |
|
130
Vaxcyte
PCVX
$7.81B
| $19.5M | 0.23% |
390,456
+140,456
| +56% | +$6.66M |
|
131
Varonis Systems
VRNS
$4.59B
| $19.5M | 0.23% |
731,163
+203,625
| +39% | +$5.08M |
|
132
Amylyx Pharmaceuticals
AMLX
$2.26B
| $19.4M | 0.23% |
899,300
+465,100
| +107% | +$12.6M |
|
|
SGEN
133
DELISTED
Seagen Inc. Common Stock
SGEN
| $19.3M | 0.23% |
100,500
+30,150
| +43% | +$5.99M |
|
|
CYBR
134
DELISTED
CyberArk
CYBR
| $19.2M | 0.23% |
+123,036
| New | +$17.6M |
|
135
HCA Healthcare
HCA
$87.2B
| $19.2M | 0.23% |
63,201
-179,313
| -74% | -$49.9M |
|
136
Kenvue
KVUE
$36.9B
| $18.9M | 0.22% |
+714,973
| New | +$18.6M |
|
|
AJRD
137
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $18.7M | 0.22% |
341,700
-201,000
| -37% | -$11.2M |
|
138
Edgewell Personal Care
EPC
$1.25B
| $18.7M | 0.22% |
452,804
-97,732
| -18% | -$4.18M |
|
139
Western Digital
WDC
$188B
| $18.6M | 0.22% |
650,141
+370,625
| +133% | +$10.3M |
|
140
Paylocity
PCTY
$7.38B
| $18.6M | 0.22% |
100,689
+1,695
| +2% | +$310K |
|
141
Leidos
LDOS
$14.5B
| $18.5M | 0.22% |
208,952
-150,854
| -42% | -$12.9M |
|
|
BPMC
142
DELISTED
Blueprint Medicines
BPMC
| $18.4M | 0.22% |
291,362
+185,985
| +176% | +$10.1M |
|
|
ARNC
143
DELISTED
Arconic Corporation
ARNC
| $18.1M | 0.21% |
+611,962
| New | +$16.9M |
|
144
Veeva Systems
VEEV
$33.1B
| $17.8M | 0.21% |
90,005
+11,176
| +14% | +$2.04M |
|
145
Chipotle Mexican Grill
CMG
$47.2B
| $17.6M | 0.21% |
411,150
+36,800
| +10% | +$1.46M |
|
146
Trane Technologies
TT
$100B
| $17.4M | 0.21% |
+90,774
| New | +$16.1M |
|
147
Encompass Health
EHC
$11B
| $17.3M | 0.2% |
+254,867
| New | +$16M |
|
148
Bausch + Lomb
BLCO
$6.04B
| $16.7M | 0.2% |
832,510
-855,640
| -51% | -$15.5M |
|
|
AMED
149
DELISTED
Amedisys
AMED
| $16.5M | 0.2% |
+180,902
| New | +$14.8M |
|
150
ICU Medical
ICUI
$4.21B
| $16.5M | 0.2% |
92,735
+23,953
| +35% | +$4.39M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2023 Portfolio in Review
As of Q2 2023, Woodline Partners held 838 positions worth $8.44B, up 15% from $7.35B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners deployed $577M of net new capital in Q2 2023, opening 218 new positions and adding to 181 existing holdings. Its largest new stake was Hess: 837,083 shares worth $114M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Keysight, an estimated $101M trimmed.
- Woodline Partners's largest Q2 2023 buy was Hess: 837,083 shares worth $114M.
- Woodline Partners added most to Johnson & Johnson in Q2 2023, an estimated $123M increase.
- Woodline Partners's biggest Q2 2023 reduction was Keysight, cutting an estimated $101M.
- Woodline Partners fully exited Baxter International in Q2 2023, selling an estimated $108M.
- Woodline Partners's ten largest holdings make up 16% of its $8.44B portfolio in Q2 2023.
- Woodline Partners opened 218 new positions and closed 220 in Q2 2023.
- Woodline Partners's portfolio value rose 15% quarter-over-quarter to $8.44B.
Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.